Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 9—September 2017
Dispatch

Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France

Yahia Benzerara, Salah Gallah, Baptiste Hommeril, Nathalie Genel, Dominique Decré, Martin Rottman, and Guillaume ArletComments to Author 
Author affiliations: Assistance Publique des Hôpitaux de Paris Hôpitaux Universitaires Est Parisiens Paris, France (Y. Benzerara, S. Gallah, B. Hommeril, D. Decré, G. Arlet); Université Pierre et Marie Curie, Sorbonne Université, Paris (N. Genel, D. Decré, G. Arlet); Assistance Publique des Hôpitaux de Paris Hôpitaux Universitaires Paris Ile de France Ouest, Hôpital Raymond Poincaré, Garches, France (M. Rottman); Université de Versailles Saint-Quentin-en-Yvelines, St-Quentin en Yvelines, France (M. Rottman)

Main Article

Table 1

Oligonucleotide primers used in our study for detection of plasmid-mediated fosfomycin-resistance genes

fosC2 Fwd TGGAGGCTACTTGGATTTG 50 209 (8)
Rev AGGCTACCGCTATGGATTT

*Fwd, forward; Rev, reverse.

Main Article

References
  1. Société de Pathologie Infectieuse de Langue Française. Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires de l’adulte [cited 2017 Jun 21]. http://www.infectiologie.com/UserFiles/File/spilf/recos/infections-urinaires-spilf.pdf
  2. Agence Nationale de Sécurité du Médicaments. Etude d’utilisation de la nitrofurantoïne en France—période mars 2012–février 2015 [cited 2017 Jun 21]. http://ansm.sante.fr/var/ansm_site/storage/original/application/d807c8e39321445201911cf314263f07.pdf
  3. Kaye  KS, Gales  AC, Dubourg  G. Old antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes. Int J Antimicrob Agents. 2017;49:542–8. DOIPubMedGoogle Scholar
  4. Castañeda-García  A, Blázquez  J, Rodríguez-Rojas  A. Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance. Antibiotics (Basel). 2013;2:217–36. DOIPubMedGoogle Scholar
  5. Ho  PL, Chan  J, Lo  WU, Lai  EL, Cheung  YY, Lau  TC, et al. Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates. J Med Microbiol. 2013;62:1707–13. DOIPubMedGoogle Scholar
  6. Lee  SY, Park  YJ, Yu  JK, Jung  S, Kim  Y, Jeong  SH, et al. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J Antimicrob Chemother. 2012;67:2843–7. DOIPubMedGoogle Scholar
  7. Wachino  J, Yamane  K, Suzuki  S, Kimura  K, Arakawa  Y. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother. 2010;54:3061–4. DOIPubMedGoogle Scholar
  8. Hou  J, Huang  X, Deng  Y, He  L, Yang  T, Zeng  Z, et al. Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China. Antimicrob Agents Chemother. 2012;56:2135–8. DOIPubMedGoogle Scholar
  9. Chan  J, Lo  WU, Chow  KH, Lai  EL, Law  PY, Ho  PL. Clonal diversity of Escherichia coli isolates carrying plasmid-mediated fosfomycin resistance gene fosA3 from livestock and other animals. Antimicrob Agents Chemother. 2014;58:5638–9. DOIPubMedGoogle Scholar
  10. Hou  J, Yang  X, Zeng  Z, Lv  L, Yang  T, Lin  D, et al. Detection of the plasmid-encoded fosfomycin resistance gene fosA3 in Escherichia coli of food-animal origin. J Antimicrob Chemother. 2013;68:766–70. DOIPubMedGoogle Scholar
  11. Mendes  AC, Rodrigues  C, Pires  J, Amorim  J, Ramos  MH, Novais  Â, et al. Importation of fosfomycin resistance fosA3 gene to Europe. Emerg Infect Dis. 2016;22:346–8. DOIPubMedGoogle Scholar
  12. Nakamura  G, Wachino  J, Sato  N, Kimura  K, Yamada  K, Jin  W, et al. Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases. J Clin Microbiol. 2014;52:3175–9. DOIPubMedGoogle Scholar
  13. Ma  Y, Xu  X, Guo  Q, Wang  P, Wang  W, Wang  M. Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli. Lett Appl Microbiol. 2015;60:259–64. DOIPubMedGoogle Scholar
  14. Compain  F, Poisson  A, Le Hello  S, Branger  C, Weill  FX, Arlet  G, et al. Targeting relaxase genes for classification of the predominant plasmids in Enterobacteriaceae. Int J Med Microbiol. 2014;304:236–42. DOIPubMedGoogle Scholar
  15. Al-Tawfiq  JA, Laxminarayan  R, Mendelson  M. How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals? Int J Infect Dis. 2017;54:77–84. DOIPubMedGoogle Scholar

Main Article

Page created: August 17, 2017
Page updated: August 17, 2017
Page reviewed: August 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external